Abiraterone Acetate
- Product NDC
- 51407-181
- 11-digit product format
- 514070181
- Labeler code
- 51407
- Product ID
- 51407-181_e0cf4bd0-c435-b422-e053-2995a90a62e1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- abiraterone acetate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Golden State Medical Supply, Inc.
- Application
- ANDA208446
- Marketing category
- ANDA
- Marketing start
- 2018-10-31
- Marketing end
- 0000-00-00
- Substance
- ABIRATERONE ACETATE
- Active strength
- 250 mg/1
- Pharmacologic classes
- Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51407-181-12 | 51407018112 | 120 TABLET in 1 BOTTLE, PLASTIC (51407-181-12) | 120 tablet | 2019-01-16 | 0000-00-00 | No | No | Current |